Ownership history in FISHMAN JAY A LTD/MI · 15 quarters on record
This page tracks every 13F SEC filing in which FISHMAN JAY A LTD/MI reported a position in ARCUTIS BIOTHERAPEUTICS INC (ARQT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 564,650 | -1,000 | -0.2% | 1.35% | $16.4M | $29.04 |
| 2025 Q3 | ADDED | 565,650 | +9,500 | +1.7% | 0.91% | $10.7M | $18.85 |
| 2025 Q2 | ADDED | 556,150 | +23,000 | +4.3% | 0.75% | $7.8M | $14.02 |
| 2025 Q1 | REDUCED | 533,150 | -3,250 | -0.6% | 0.91% | $8.3M | $15.64 |
| 2024 Q4 | ADDED | 536,400 | +118,400 | +28.3% | 0.70% | $7.5M | $13.93 |
| 2024 Q3 | ADDED | 418,000 | +403,966 | +2878.5% | 0.39% | $3.9M | $9.30 |
| 2024 Q2 | REDUCED | 14,034 | -210,266 | -93.7% | 0.34% | $3.2M | $9.30 |
| 2024 Q1 | ADDED | 224,300 | +171,300 | +323.2% | 0.25% | $2.2M | $9.91 |
| 2023 Q4 | REDUCED | 53,000 | -34,000 | -39.1% | 0.02% | $171K | $3.23 |
| 2023 Q3 | ADDED | 87,000 | +10,000 | +13.0% | 0.06% | $462K | $5.31 |
As of 2025 Q4 — sorted by position size